ArticleTargeted oncology2014

Anti-Sp17 monoclonal antibody-doxorubicin conjugates as molecularly targeted chemotherapy for ovarian carcinoma.

Jia-Xi Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.